Table 1 Comparison of baseline data of the two groups.

From: Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis

 

GROUP A (n = 160)a

GROUP B (n = 181)b

Two-tailed P value

Mean (SD)

Mean (SD)

Age (SD) (year)

34.56 (4.49)

35.25 (4.95)

0.18

Height (SD) (cm)

162.63 (5.57)

161.56 (5.29)

0.08

Weight (SD) (kg)

64.99 (11.04)

63.76 (9.42)

0.27

BMI (SD)

24.56 (3.87)

24.43 (3.42)

0.73

Laboratory tests

FSH (SD) (IU/L)

6.54 (1.89)

6.32 (2.04)

0.31

LH (SD) (IU/L)

4.39 (2.05)

4.85 (2.57)

0.07

E2 (SD) (Pg/ml)

42.38 (33.86)

48.08 (76.54)

0.39

PRL (SD) (ng/ml)

19.87 (35.15)

16.76 (19.48)c

0.31

Infertility

  

0.19

Primary infertility—no./total no. (%)

65/160 (40.62)

61/181 (33.70)

 

Secondary infertility—no./total no. (%)

95/160 (59.38)

120/181 (66.30)

 

Endometrial thickness on hCG trigger day (cm)

0.96 (0.20)d

0.91 (0.18)

0.02

Duration of infertility (year)

4.07 (3.27)

4.29 (3.45)

0.55

Causes of infertility-no./total no. (%)

  

0.41

Female factors

146/160 (91.25)

169/181 (93.89)

 

Male and female factors

11/160 (6.88)

7/181 (3.87)

 

Unknown factors

3/160 (1.87)

5/181 (2.74)

 
  1. aIn the study group (n = 160), GnRH-a was added based on GnRH-a before hormone administration to adjust the menstruation cycle.
  2. bThe control group (n = 181) was treated only with an artificial hormone cycle to prepare the endometrium.
  3. cOne value was missing.
  4. dFive values were missing.
Back to article page